Navigation Links
Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
Date:2/14/2008

- New Data Presented at American Society of Clinical Oncology's

Genitourinary Symposium -

SEATTLE and SAN FRANCISCO, Feb. 14 /PRNewswire-FirstCall/ -- Researchers from Dendreon Corporation (Nasdaq: DNDN) today presented data demonstrating the correlation of a measure of the cumulative potency of PROVENGE (sipuleucel-T), an investigational active cellular immunotherapy for hormone-refractory prostate cancer, with overall survival. This is the first time that an association between higher potency of an active immune therapy and increased patient survival has been reported. The correlation appeared to be independent of other important baseline prognostic factors.

The abstract (#21), "Cell Number and CD54 Expression in Sipuleucel-T Correlate with Survival in Metastatic Androgen Independent Prostate Cancer," is being presented at the American Society of Clinical Oncology's 2008 Genitourinary Symposium in San Francisco.

In two Phase 3 trials, D9901 and D9902A, researchers evaluated cumulative product release parameters of PROVENGE, including CD54 upregulation (a measure of product potency defined as the increase of CD54 molecules expressed on Antigen Presenting Cells [APC] after incubation with the PROVENGE Antigen Delivery Cassette(TM)) and the number of total nucleated cells (TNCs) among patients treated with sipuleucel-T (n=146). CD54 is a costimulatory molecule which serves as a marker for APCs. Its expression is increased when APCs become activated and this upregulation of CD54 serves as a potency release assay for PROVENGE.

Results showed that PROVENGE patients experienced improved survival if they received more cells across the three doses of PROVENGE (higher cumulative TNC count (
'/>"/>

SOURCE Dendreon Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
3. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
4. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
5. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
6. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
7. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
8. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
9. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
10. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
11. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... NORWALK, Conn. , July 23, 2014 ... NeurologyTimes.com – a new online community and information ... them better manage and treat their patients with ... conditions, coupled with an aging population, necessitates greater access ... specific disorders.  Key statistics on neurological conditions include: ...
(Date:7/23/2014)... , July 23, 2014 Pharmavite LLC announced ... chief customer officer effective immediately. Toll recently served as ... and marketing, category management, private label and sales administration ... his new global role, Toll will expand his responsibilities ... planning. "Toll,s appointment to chief customer officer ...
(Date:7/23/2014)... July 23, 2014 Research and ... "Global Electrophysiology Ablation Catheters Market 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 Catheter ablation is ... destroy faulty electrical pathways from sections of the ... as cardiac arrhythmias). Cardiac arrhythmias can be of ...
Breaking Medicine Technology:UBM Medica US Launches NeurologyTimes.com 2UBM Medica US Launches NeurologyTimes.com 3Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 2Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 3
... March 16, 2011 /PRNewswire-Asia-FirstCall/ -- ... "Company") (Nasdaq: CMED ... in-vitro diagnostic ("IVD") company, today ... investors at the following investor ...
... SHENZHEN, China, March 16, 2011 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain ... Company"), the largest retail drugstore chain in China based on ... financial results for the fourth quarter and fiscal year ended ... HighlightsFor the quarter ended December 31, 2010: Same ...
Cached Medicine Technology:China Medical Technologies to Meet Investors 2China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 2China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 3China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 4China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 5China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 6China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 7China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 8China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 9China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 10China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 11China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 12
(Date:7/23/2014)... WEDNESDAY, July 23, 2014 (HealthDay News) -- Painful or ... skin cancer, researchers report. "Patients sometimes have multiple ... itchy or painful should raise high concerns for non-melanoma ... dermatology at Temple University School of Medicine, said in ... looked at the medical records of 268 patients who ...
(Date:7/23/2014)... Officials from China,s Northwest Agricultural and Forestry University in ... signed a memorandum of agreement that lays the groundwork ... Safety in China. , The signing ceremony was held ... between high-level officials of the U.S. Department of Agriculture ... agreement is a landmark event for UC Davis and ...
(Date:7/23/2014)... The American Telemedicine Association (ATA) ... annual meeting and tradeshow focused exclusively on telemedicine, ... over 5,000 attendees and more than 250 cutting-edge ... 2015, in Los Angeles. , ATA’s annual meeting ... from researchers, clinicians, hospital and university administrators, program ...
(Date:7/23/2014)... 23, 2014 Bodybuilding.com, the Internet’s most-visited ... of nutritional supplements, has officially opened the polls for ... , the fastest growing sports nutrition company, is up ... of the Year, Best Tasting Protein of the Year- ... of the year - Whey-HD™, Pre-workout Supplement of the ...
(Date:7/23/2014)... The voice on the recording was low and ... news he was infected with the human immunodeficiency virus (HIV) that ... next thing you know I was on the floor flat on ... was hopeful when the recording ended less than 10 minutes later. ... . because it is just God setting you up for ...
Breaking Medicine News(10 mins):Health News:Painful, Itchy Patches Could Be Sign of Skin Cancer 2Health News:Global food safety research agreement signed by China and UC Davis 2Health News:Global food safety research agreement signed by China and UC Davis 3Health News:ATA Seeks Speakers to Present at the World’s Largest Telemedicine, mHealth and Telehealth Conference 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 3Health News:HIV clinic-based audio project emphasizes the power of patient voices 2Health News:HIV clinic-based audio project emphasizes the power of patient voices 3
... Trust for America,s Health (TFAH) ... today entitled Health Care vs. Sick Care. , ... chance to transform our health care system from a sick ... Jeff Levi, PhD, Executive Director of TFAH. "The evidence is ...
... Oct. 28 The cutting-edge of assistive technology--including ... showcased at the Assistive Technology Pavilion at Abilities ... 6-8, 2009 at the Cobb Galleria Convention Center. ... caregivers and healthcare professionals are expected to attend ...
... Inc. (TSX: NRI), a Canadian drug development company focused on ... to and through the skin using its topical and transdermal ... its immune modulating drug candidate, WF10, today announced its financial ... , , Reent Corporate Developments:, ...
... ... digital radiology laboratory, Spencer Peller of 123Chiropractors.com presents the donation check to Life West ... ... November 3, 2009 -- 123Chiropractors.com, http://www.123chiropractors.com , the world,s largest portal relating to ...
... TORONTO, Oct. 28 /PRNewswire/ - LPBP Inc. (the ... 2009 press release related to the per share ... The per share dividend on the Class B ... on the Class A Common shares of $0.0099 ...
... to examine how physicians care for patients from diverse ... Oct. 28 Connecticut physicians believe they could be ... and ethnic backgrounds if they had training that was ... released today by the Connecticut State Medical Society. ...
Cached Medicine News:Health News:New Health Care vs. Sick Care Ad Campaign Launched by Trust for America's Health and Partnership for Prevention 2Health News:New Health Care vs. Sick Care Ad Campaign Launched by Trust for America's Health and Partnership for Prevention 3Health News:Experience the Future of Assistive Technology at Abilities Expo on November 6-8, 2009 2Health News:Nuvo announces 2009 third quarter financial results 2Health News:Nuvo announces 2009 third quarter financial results 3Health News:Nuvo announces 2009 third quarter financial results 4Health News:Nuvo announces 2009 third quarter financial results 5Health News:Nuvo announces 2009 third quarter financial results 6Health News:Nuvo announces 2009 third quarter financial results 7Health News:Nuvo announces 2009 third quarter financial results 8Health News:Nuvo announces 2009 third quarter financial results 9Health News:Nuvo announces 2009 third quarter financial results 10Health News:Nuvo announces 2009 third quarter financial results 11Health News:Nuvo announces 2009 third quarter financial results 12Health News:World's Largest Resource for and about Chiropractors, 123Chiropractors.com, Donates $15,000 to Life Chiropractic College West 2Health News:World's Largest Resource for and about Chiropractors, 123Chiropractors.com, Donates $15,000 to Life Chiropractic College West 3Health News:CSMS Issues Results of Health Disparities Survey 2
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
The ACMI™ line of laparoscopic hand instruments is designed to provide a wide selection of popular surgical devices to meet procedural needs....
Insulated, angled, spoon-shaped design cups the gallbladder, permits clear visualization, and allows easy dissection and control of bleeders....
Medicine Products: